[Form 3] Aimei Health Technology Co., Ltd. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Aimei Health Technology Co., Ltd. director Daniel Veikko Polvi filed an initial Form 3, which is a statement of beneficial ownership for insiders. The filing shows no reportable transactions, with zero shares reported as bought, sold, or otherwise transacted in this excerpt.

Key Figures

BuyShares: 0 shares SellShares: 0 shares NetBuySellShares: 0 shares

3 metrics

BuyShares 0 shares Shares bought reported in Form 3 summary

SellShares 0 shares Shares sold reported in Form 3 summary

NetBuySellShares 0 shares Net share activity in transactionSummary

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"Form 3, which is a statement of beneficial ownership for insiders"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"Form 3, which is a statement of beneficial ownership for insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"The Form 3 for Aimei Health Technology Co., Ltd. shows director Daniel Veikko Polvi’s initial insider status as a reporting person"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/01/2026 - 11:17 AM Accepted by SEC EDGAR 07/01/2026 - 11:16 AM Learn about SEC filing dates

FAQ

What does Daniel Veikko Polvi’s Form 3 filing for AFJK show?

The Form 3 for Aimei Health Technology Co., Ltd. shows director Daniel Veikko Polvi’s initial insider status. The summary data reports no shares bought, sold, or otherwise transacted and no derivative positions in the excerpt provided.

Did Daniel Veikko Polvi buy or sell AFJK shares in this Form 3?

No, this Form 3 reports no AFJK share purchases or sales by Daniel Veikko Polvi. BuyShares and sellShares are both listed as zero, and netBuySellShares is also zero, indicating no reported trading activity.

Does the AFJK Form 3 indicate any derivative positions for Daniel Veikko Polvi?

The AFJK Form 3 indicates no derivative positions for Daniel Veikko Polvi in the excerpt. The derivativeSummary is empty and derivativeTransactionCount is zero, suggesting no options, warrants, or other derivatives are reported here.

Is Daniel Veikko Polvi a ten percent owner of Aimei Health Technology (AFJK)?

The Form 3 indicates Daniel Veikko Polvi is not a ten percent owner of AFJK. The is_ten_percent_owner field is zero, while he is identified as a director, clarifying his insider role without large ownership status.

What is the net share activity reported in this AFJK Form 3?

Net share activity in this AFJK Form 3 is zero. NetBuySellShares is listed as zero and netBuySellDirection is neutral, reflecting that no insider trading transactions are reported in this initial ownership statement.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Polvi Daniel Veikko

(Last) (First) (Middle)

APT 802, BUILDING 9A, SOUTHERN AREA,

ESTHETIC MANSION

(Street)

CHANGZHOU 213001

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/29/2026

3. Issuer Name and Ticker or Trading Symbol
Aimei Health Technology Co., Ltd. [ AFJK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Daniel Veikko Polvi	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)